Published in BMC Microbiol on February 04, 2009
Photodynamic therapy for localized infections--state of the art. Photodiagnosis Photodyn Ther (2009) 1.73
Methylene blue: revisited. J Anaesthesiol Clin Pharmacol (2010) 1.23
Photodynamic inactivation of Acinetobacter baumannii using phenothiazinium dyes: in vitro and in vivo studies. Lasers Surg Med (2010) 1.12
Animal models of external traumatic wound infections. Virulence (2011) 1.07
Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol (2012) 1.07
All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease. Virulence (2011) 1.05
Multiresistant strains are as susceptible to photodynamic inactivation as their naïve counterparts: protoporphyrin IX-mediated photoinactivation reveals differences between methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains. Photomed Laser Surg (2014) 0.93
Antimicrobial photodynamic therapy to kill Gram-negative bacteria. Recent Pat Antiinfect Drug Discov (2013) 0.93
Optimal photosensitizers for photodynamic therapy of infections should kill bacteria but spare neutrophils. Photochem Photobiol (2011) 0.90
Photodynamic therapy using intra-articular Photofrin for murine MRSA arthritis: biphasic light dose response for neutrophil-mediated antibacterial effect. Lasers Surg Med (2011) 0.88
Magnetic nanoparticle targeted hyperthermia of cutaneous Staphylococcus aureus infection. Ann Biomed Eng (2012) 0.87
Microbial growth inhibition by alternating electric fields in mice with Pseudomonas aeruginosa lung infection. Antimicrob Agents Chemother (2010) 0.87
Applications of flow cytometry to characterize bacterial physiological responses. Biomed Res Int (2014) 0.86
Photodynamic therapy can induce a protective innate immune response against murine bacterial arthritis via neutrophil accumulation. PLoS One (2012) 0.86
Can biowarfare agents be defeated with light? Virulence (2013) 0.86
Efficient photodynamic therapy against gram-positive and gram-negative bacteria using THPTS, a cationic photosensitizer excited by infrared wavelength. PLoS One (2010) 0.86
Safety assessment of oral photodynamic therapy in rats. Lasers Med Sci (2012) 0.85
Cationic porphycenes as potential photosensitizers for antimicrobial photodynamic therapy. J Med Chem (2010) 0.84
Chemical and biological mechanisms of pathogen reduction technologies. Photochem Photobiol (2014) 0.82
Photodynamic therapy induces an immune response against a bacterial pathogen. Expert Rev Clin Immunol (2012) 0.82
Antimicrobial photodynamic therapy for methicillin-resistant Staphylococcus aureus infection. Biomed Res Int (2013) 0.82
Safe thyroidectomy with intraoperative methylene blue spraying. Thyroid Res (2012) 0.81
Study of photodynamic therapy in the control of isolated microorganisms from infected wounds--an in vitro study. Lasers Med Sci (2013) 0.80
Eradication of bacteria in suspension and biofilms using methylene blue-loaded dynamic nanoplatforms. Antimicrob Agents Chemother (2009) 0.79
Beyond the margins: real-time detection of cancer using targeted fluorophores. Nat Rev Clin Oncol (2017) 0.78
PharmGKB summary: methylene blue pathway. Pharmacogenet Genomics (2013) 0.78
Hydrogen bond acceptors and additional cationic charges in methylene blue derivatives: photophysics and antimicrobial efficiency. Biomed Res Int (2012) 0.78
Staphylococcus aureus small colony variants are susceptible to light activated antimicrobial agents. BMC Microbiol (2013) 0.76
Photodynamic inactivation of antibiotic-resistant bacteria and biofilms by hematoporphyrin monomethyl ether. Lasers Med Sci (2015) 0.76
Analysis of Healing Effect of Alginate Sulfate Hydrogel Dressing Containing Antimicrobial Peptide on Wound Infection Caused by Methicillin-Resistant Staphylococcus aureus. Jundishapur J Microbiol (2015) 0.75
Histological Evaluation of Wound Healing Process after Photodynamic Therapy of Rat Oral Mucosal Ulcer. J Dent (Shiraz) (2016) 0.75
Murine Model Imitating Chronic Wound Infections for Evaluation of Antimicrobial Photodynamic Therapy Efficacy. Front Microbiol (2016) 0.75
Nanoparticle-Based Therapies for Wound Biofilm Infection: Opportunities and Challenges. IEEE Trans Nanobioscience (2016) 0.75
Water-soluble benzylidene cyclopentanone based photosensitizers for in vitro and in vivo antimicrobial photodynamic therapy. Sci Rep (2016) 0.75
A Review of the Recent Advances in Antimicrobial Coatings for Urinary Catheters. Acta Biomater (2016) 0.75
Methylene Blue-Loaded Dissolving Microneedles: Potential Use in Photodynamic Antimicrobial Chemotherapy of Infected Wounds. Pharmaceutics (2015) 0.75
Study of Methylene Blue Ototoxicity in the Guinea Pig. J Clin Med Res (2017) 0.75
Mechanistic aspects of the photodynamic inactivation of vancomycin-resistant Enterococci mediated by 5-aminolevulinic acid and 5-aminolevulinic acid methyl ester. Curr Microbiol (2014) 0.75
Photodynamic therapy controls of Staphylococcus aureus intradermal infection in mice. Lasers Med Sci (2017) 0.75
Characterization of blue light irradiation effects on pathogenic and nonpathogenic Escherichia coli. Microbiologyopen (2017) 0.75
Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. British Society for Antimicrobial Chemotherapy, Hospital Infection Society and the Infection Control Nurses Association. J Hosp Infect (1998) 6.39
The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol (2005) 5.86
Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem Photobiol Sci (2004) 4.60
Photodynamic antimicrobial chemotherapy (PACT). J Antimicrob Chemother (1998) 3.26
The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect (2007) 3.24
Photodynamic therapy in the treatment of microbial infections: basic principles and perspective applications. Lasers Surg Med (2006) 2.27
Rapid control of wound infections by targeted photodynamic therapy monitored by in vivo bioluminescence imaging. Photochem Photobiol (2002) 2.18
Optical monitoring and treatment of potentially lethal wound infections in vivo. J Infect Dis (2003) 1.98
Targeted photodynamic therapy of established soft-tissue infections in mice. Photochem Photobiol Sci (2004) 1.57
Photobactericidal activity of phenothiazinium dyes against methicillin-resistant strains of Staphylococcus aureus. FEMS Microbiol Lett (1998) 1.54
Killing of cutaneous microbial species by photodynamic therapy. Br J Dermatol (2001) 1.52
Community-acquired MRSA: can we control it? Lancet (2006) 1.52
Photosensitized inactivation of microorganisms. Photochem Photobiol Sci (2004) 1.32
The effect of photodynamic action on two virulence factors of gram-negative bacteria. Photochem Photobiol (2000) 1.30
Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice. Photochem Photobiol Sci (2005) 1.29
Wound healing in cell studies and animal model experiments by Low Level Laser Therapy; were clinical studies justified? a systematic review. Lasers Med Sci (2002) 1.25
Treatment of periodontal disease by photodisinfection compared to scaling and root planing. J Clin Dent (2007) 1.21
Susceptibilities to antiseptic agents and distribution of antiseptic-resistance genes qacA/B and smr of methicillin-resistant Staphylococcus aureus isolated in Asia during 1998 and 1999. J Med Microbiol (2005) 1.18
Oral bacteria in multi-species biofilms can be killed by red light in the presence of toluidine blue. Lasers Surg Med (2002) 1.18
The use of porphyrins for eradication of Staphylococcus aureus in burn wound infections. FEMS Immunol Med Microbiol (1997) 1.11
Killing of methicillin-resistant Staphylococcus aureus by low-power laser light. J Med Microbiol (1995) 1.08
Toluidine blue-mediated photodynamic effects on staphylococcal biofilms. Antimicrob Agents Chemother (2007) 1.05
Lethal photosensitisation of Staphylococcus aureus in vitro: effect of growth phase, serum, and pre-irradiation time. Lasers Surg Med (1995) 1.00
Large variation in MRSA policies, procedures and prevalence in English intensive care units: a questionnaire analysis. Intensive Care Med (2003) 0.88
Inactivation of Proteolytic Enzymes from Porphyromonas gingivalis Using Light-activated Agents. Lasers Med Sci (2000) 0.87
An investigation of the thermal inactivation of Staphylococcus aureus and the potential for increased thermotolerance as a result of chilled storage. J Appl Microbiol (2005) 0.86
Effect of photodynamic therapy on the healing of a rat skin flap and its implication for head and neck reconstructive surgery. Lasers Surg Med (1996) 0.84
Temperature monitoring during photodynamic therapy of skin tumors with topical 5-aminolevulinic acid application. Cancer Lett (1995) 0.82
Mathematical models for conventional and microwave thermal deactivation of Enterococcus faecalis, Staphylococcus aureus and Escherichia coli. Cell Mol Biol (Noisy-le-grand) (2007) 0.81
Hydrocortisone therapy for patients with septic shock. N Engl J Med (2008) 15.85
Multiple-laboratory comparison of microarray platforms. Nat Methods (2005) 11.74
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA (2009) 9.47
HMDB 3.0--The Human Metabolome Database in 2013. Nucleic Acids Res (2012) 9.21
Trial of early, goal-directed resuscitation for septic shock. N Engl J Med (2015) 8.24
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet (2002) 7.58
Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA (2013) 7.23
DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res (2013) 6.73
Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet (2005) 6.33
Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med (2008) 5.30
Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet (2005) 5.01
Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet (2002) 4.42
Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 3.50
The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med (2009) 3.30
Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature (2012) 3.09
Assessment of the accuracy of portion size reports using computer-based food photographs aids in the development of an automated self-administered 24-hour recall. J Am Diet Assoc (2010) 2.95
Improvement of pathology in sub-Saharan Africa. Lancet Oncol (2013) 2.88
A novel aux/IAA28 signaling cascade activates GATA23-dependent specification of lateral root founder cell identity. Curr Biol (2010) 2.81
Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med (2007) 2.79
Statin use and mortality in the bacteremic critically ill patient. Crit Care Med (2006) 2.57
Robotic cloning and Protein Production Platform of the Northeast Structural Genomics Consortium. Methods Enzymol (2005) 2.54
Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer? J Trauma (2008) 2.52
Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med (2010) 2.48
The Pancreatitis Outcome Prediction (POP) Score: a new prognostic index for patients with severe acute pancreatitis. Crit Care Med (2007) 2.45
Rapid Diagnosis of Infection in the Critically Ill, a Multicenter Study of Molecular Detection in Bloodstream Infections, Pneumonia, and Sterile Site Infections. Crit Care Med (2015) 2.37
Prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients. Intensive Care Med (2012) 2.33
Mechanisms of sepsis-induced organ dysfunction. Crit Care Med (2007) 2.30
The impact of enhanced cleaning within the intensive care unit on contamination of the near-patient environment with hospital pathogens: a randomized crossover study in critical care units in two hospitals. Crit Care Med (2011) 2.23
Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics (2012) 2.18
Medication errors: a prospective cohort study of hand-written and computerised physician order entry in the intensive care unit. Crit Care (2005) 2.03
Understanding the benefits and harms of oxygen therapy. Intensive Care Med (2015) 2.00
Terlipressin for norepinephrine-resistant septic shock. Lancet (2002) 1.99
Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting? Crit Care Med (2009) 1.99
Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol (2003) 1.95
maxdLoad2 and maxdBrowse: standards-compliant tools for microarray experimental annotation, data management and dissemination. BMC Bioinformatics (2005) 1.94
Measurement of H2O2 within living Drosophila during aging using a ratiometric mass spectrometry probe targeted to the mitochondrial matrix. Cell Metab (2011) 1.87
Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med (2005) 1.83
Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study. Crit Care Med (2013) 1.81
Standard nomenclature for the superantigens expressed by Staphylococcus. J Infect Dis (2004) 1.78
Variability in management of early severe sepsis. Emerg Med J (2010) 1.76
Tracking changes in cardiac output: methodological considerations for the validation of monitoring devices. Intensive Care Med (2009) 1.76
Hypoxia accelerates nitric oxide-dependent inhibition of mitochondrial complex I in activated macrophages. Am J Physiol Regul Integr Comp Physiol (2004) 1.74
Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med (2007) 1.74
H1N1 pneumonitis treated with intravenous zanamivir. Lancet (2009) 1.73
Potential metabolic consequences of statins in sepsis. Crit Care Med (2011) 1.64
Clinical review: Update on hemodynamic monitoring--a consensus of 16. Crit Care (2011) 1.62
Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis. Crit Care Med (2007) 1.58
Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans. Annu Rev Microbiol (2003) 1.57
Temporal changes in tissue cardiorespiratory function during faecal peritonitis. Intensive Care Med (2011) 1.54
Microvascular and interstitial oxygen tension in the renal cortex and medulla studied in a 4-h rat model of LPS-induced endotoxemia. Shock (2011) 1.52
Differential effects of vasopressin and norepinephrine on vascular reactivity in a long-term rodent model of sepsis. Crit Care Med (2007) 1.50
Prevalence of malnutrition and nutritional risk factors in patients undergoing alcohol and drug treatment. Nutrition (2012) 1.48
Post hoc insights from PAC-Man--the U.K. pulmonary artery catheter trial. Crit Care Med (2008) 1.48
The impact of inspired oxygen concentration on tissue oxygenation during progressive haemorrhage. Intensive Care Med (2009) 1.48
YMDB: the Yeast Metabolome Database. Nucleic Acids Res (2011) 1.48
Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol (2006) 1.48
Can thallium-pertechnetate subtraction scanning play a role in the preoperative imaging for minimally invasive parathyroidectomy? Clin Nucl Med (2004) 1.47
Environmental factors associated with the distribution of Anopheles gambiae s.s in Ghana; an important vector of lymphatic filariasis and malaria. PLoS One (2010) 1.46
Low-molecular-weight polyethylene glycol improves survival in experimental sepsis. Crit Care Med (2010) 1.45
Critical care: advances and future perspectives. Lancet (2010) 1.44
Intensive care and emergency medicine: progress over the past 25 years. Chest (2006) 1.43
Identification of a fibronectin-binding protein from Staphylococcus epidermidis. Infect Immun (2002) 1.43
The FTc is not an accurate marker of left ventricular preload. Intensive Care Med (2006) 1.42
Unraveling the evolution of auxin signaling. Plant Physiol (2010) 1.41
Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX). Crit Care Med (2015) 1.40
Epidemiology of hookworm infection in Kintampo North Municipality, Ghana: patterns of malaria coinfection, anemia, and albendazole treatment failure. Am J Trop Med Hyg (2011) 1.40
ECMDB: the E. coli Metabolome Database. Nucleic Acids Res (2012) 1.38
Inhibition of vascular adenosine triphosphate-sensitive potassium channels by sympathetic tone during sepsis. Crit Care Med (2012) 1.38
The validity of trans-esophageal Doppler ultrasonography as a measure of cardiac output in critically ill adults. Intensive Care Med (2004) 1.37
Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects. J Biol Chem (2007) 1.37
Distribution of tetracycline and erythromycin resistance genes among human oral and fecal metagenomic DNA. Microb Drug Resist (2009) 1.35
Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation (2005) 1.33
Bench-to-bedside review: potential strategies to protect or reverse mitochondrial dysfunction in sepsis-induced organ failure. Crit Care (2006) 1.30
Mitochondrial Dysfunction in Sepsis. Curr Infect Dis Rep (2003) 1.30
Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats. Crit Care Med (2010) 1.30
SMPDB 2.0: big improvements to the Small Molecule Pathway Database. Nucleic Acids Res (2013) 1.29
Cellular energetic metabolism in sepsis: the need for a systems approach. Biochim Biophys Acta (2008) 1.28
Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med (2007) 1.28
Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis. PLoS Med (2012) 1.27
TREM-1 promotes survival during septic shock in mice. Eur J Immunol (2007) 1.27
Interaction of staphylococci with bone. Int J Med Microbiol (2009) 1.23
Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication. Crit Care (2010) 1.22
Radioguided parathyroidectomy via VATS combined with intraoperative parathyroid hormone testing: the surgical approach of choice for patients with mediastinal parathyroid adenomas? J Bone Miner Res (2002) 1.22
Treatment of periodontal disease by photodisinfection compared to scaling and root planing. J Clin Dent (2007) 1.21
Statistical analyses of complex denaturing gradient gel electrophoresis profiles. J Clin Microbiol (2005) 1.18
Oral bacteria in multi-species biofilms can be killed by red light in the presence of toluidine blue. Lasers Surg Med (2002) 1.18
British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals 2011. HIV Med (2011) 1.17
The heart in sepsis: from basic mechanisms to clinical management. Curr Vasc Pharmacol (2013) 1.16
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med (2017) 1.15
Development of a novel targeting system for lethal photosensitization of antibiotic-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother (2005) 1.14
Oral health in children with chronic renal failure. Pediatr Nephrol (2002) 1.14
Design and implementation of a controlled clinical trial to evaluate the effectiveness and efficiency of routine opt-out rapid human immunodeficiency virus screening in the emergency department. Acad Emerg Med (2009) 1.13
Cultivable oral microbiota of domestic dogs. J Clin Microbiol (2005) 1.11
Characterization of Tn916S, a Tn916-like element containing the tetracycline resistance determinant tet(S). J Bacteriol (2004) 1.11
Invasion of bone cells by Staphylococcus epidermidis. Microbes Infect (2007) 1.08
Tissue oxygen and hemodynamics in renal medulla, cortex, and corticomedullary junction during hemorrhage-reperfusion. Am J Physiol Renal Physiol (2006) 1.07